Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
Sponsor: Chinese Pulmonary Vascular Disease Research Group
A observational or N/A phase clinical study on PAH Targeted Medication and Percutaneous Transluminal Pulmonary Angioplasty, this trial is actively recruiting participants. The trial is conducted by Chinese Pulmonary Vascular Disease Research Group and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Feb 2023 — Jan 2024 [monthly]
Recruiting
-
Jun 2022 — Feb 2023 [monthly]
Recruiting
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Pulmonary Vascular Disease Research Group
For direct contact, visit the study record on ClinicalTrials.gov .